In the US market, in the event of a positive decision of the regulator, two new drugs for the treatment of migraine may appear at once: erenumab, jointly developed by Novartis and Amgen, and the drug freemanezumab, created by Teva Pharmaceuticals.
The dr...
13 April 2023, 12:32 ()